We are live on ! Find out more
ONCY

ONCOLYTICS BIOTECH INC

Delisted

ONCY was delisted on the 4th of November, 2015.

39 hedge funds and large institutions have $52.4M invested in ONCOLYTICS BIOTECH INC in 2013 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

129% more call options, than puts

Call options by funds: $433K | Put options by funds: $189K

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

3% more funds holding

Funds holding: 3839 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

8% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 12

22% less capital invested

Capital invested by funds: $67.5M → $52.4M (-$15.1M)

Holders
39
Holders Change
+1
Holders Change %
+2.63%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
5
Increased
11
Reduced
12
Closed
3
Calls
$433K
Puts
$189K
Net Calls
+$244K
Net Calls Change
-$1.27M

ONCY Hedge Fund Activity: Q3 2013 in Review

39 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q3 2013, worth a combined $52.4M — down 22% from $67.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ONCY positions and 3 closed out — a net gain of 2 holders — while 11 added to existing stakes and 12 trimmed.

The largest buyer was Canada Pension Plan Investment Board, adding an estimated $1.92M. The largest seller was Acuity Investment Management, cutting an estimated $5.02M.

  • 39 institutional investors held ONCOLYTICS BIOTECH INC (ONCY) as of Q3 2013, up from 38 in Q2 2013.
  • Funds reported $52.4M of ONCOLYTICS BIOTECH INC stock for Q3 2013, down 22% quarter-over-quarter.
  • 5 funds opened new ONCOLYTICS BIOTECH INC positions in Q3 2013 and 3 closed out, a net change of +2 holders.
  • The largest ONCOLYTICS BIOTECH INC buyer in Q3 2013 was Canada Pension Plan Investment Board, an estimated $1.92M added.
  • The largest ONCOLYTICS BIOTECH INC seller in Q3 2013 was Acuity Investment Management, an estimated $5.02M sold.

Based on aggregated 13F filings for Q3 2013.